Delivery of bevacizumab by intracranial injection: assessment in glioma model.

Liu, Yu-Xiao; Liu, Wen-Jia; Zhang, Hui-Ru; Zhang, Zhi-Wen

Liu, Yu-Xiao; Liu, Wen-Jia; Zhang, Hui-Ru; Zhang, Zhi-Wen.

Afiliação

Liu YX; Department of Neurosurgery, First Affiliated Hospital of Chinese PLA General Hospital, Beijing, People's Republic of China.
Liu WJ; Beijing Institute of Biotechnology, Beijing, People's Republic of China.
Zhang HR; Department of Neurosurgery, First Affiliated Hospital of Chinese PLA General Hospital, Beijing, People's Republic of China.
Zhang ZW; College of Biological Engineering, HeNan University of Technology, Beijing, People's Republic of China.

Onco Targets Ther ; 11: 2673-2683, 2018.

Article em En | MEDLINE | ID: mdl-29780259

Palavras-chave

anti-angiogenic; bevacizumab; fluorescence imaging; glioma cell line; intratumoral delivery

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2018 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google